In the SBS, a decreasing trend of the overall S . haematobium prevalence among the 9–12 year old children was observed from 2012 (6.6%) to 2019 (1.2%), with some inconsistent upturns in certain years ( Fig 2 ).
← all excerpts
Impact of seven years of mass drug administration and recrudescence of Schistosoma haematobium infections after one year of treatment gap in Zanzibar: Repeated cross-sectional studies.
1
—
—